BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23991727)

  • 1. Prostate cancer with aberrant diffuse p63 expression: report of a case and review of the literature and morphologic mimics.
    Wu A; Kunju LP
    Arch Pathol Lab Med; 2013 Sep; 137(9):1179-84. PubMed ID: 23991727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
    Stewart J; Fleshner N; Cole H; Sweet J
    J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
    Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
    Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
    Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distorted rectal tissue on prostate needle biopsy: a mimicker of prostate cancer.
    Schowinsky JT; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):866-70. PubMed ID: 16819329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical pitfalls in prostate pathology.
    Brimo F; Epstein JI
    Hum Pathol; 2012 Mar; 43(3):313-24. PubMed ID: 22325142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
    Chastain EC; Oliva IV; Osunkoya AO
    Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micropapillary carcinoma: new variant of prostatic acinar adenocarcinoma.
    Mneimneh WS; Linos K; Shah P; Jennings TA; Fisher H; Nazeer T
    Arch Pathol Lab Med; 2012 Nov; 136(11):1447-50. PubMed ID: 23106591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.
    Yaskiv O; Cao D; Humphrey PA
    Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
    Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A
    Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
    Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
    Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
    Baydar DE; Kulac I; Gurel B; De Marzo A
    Int J Surg Pathol; 2011 Feb; 19(1):131-6. PubMed ID: 20719821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
    Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
    Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratified epithelium in prostatic adenocarcinoma: a mimic of high-grade prostatic intraepithelial neoplasia.
    Hameed O; Humphrey PA
    Mod Pathol; 2006 Jul; 19(7):899-906. PubMed ID: 16607376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.